
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
EvoEnzyme is a spin-off from CSIC, Spain, which focuses its activities on the commercialization of ligninolytic enzymes engineered by directed evolution for the pharma and industrial sectors, together with the development of directed evolution projects. EvoEnzyme has just been funded after over 15 years of research at the Miguel Alcalde group, whose more relevant findings have been transferred to the company. With an ensemble of top-notch technologies, EvoEnzyme offers a variety of methods for library creation and screening aimed at designing customized biocatalysts. The company has a wide portfolio of mutant libraries, including peroxygenases for the pharma industry and chemicals...
Biotecnologia,ingenieria de enzimas,enzimas,enzimas ligninoliticas,evolucion dirigida,biotech,csic,instituto de catalisis,and premio nobel de quimica 2018
Evoenzyme operates in the Biotechnology industry.
Evoenzyme's revenue is 11m - 100m
Evoenzyme has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.